Reading EHC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track EHC free→Reading EHC? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track EHC free→QuarterlyIQ Insights · EHC
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Entry into a Material Definitive Agreement. On May 29, 2026, Encompass Health Corporation (the “Company”) completed the issuance and sale of $500 million in aggregate principal amount of its 5.875% Senior Notes due 2034 (the “Notes”), along with the related guarantees of the Notes by certain of the Company’s subsidiaries (the “Guarantees”), in a private offering. The Notes were issued at par for net proceeds of approximately $491.2 million after deducting the initial purchasers’ discount and…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The disclosure required by this item is included in
Entry into a Material Definitive Agreement. On May 14, 2026, Encompass Health Corporation (the “Company”) and certain of its subsidiaries, as guarantors (the “Guarantors”), entered into a purchase agreement (the “Purchase Agreement”) with Wells Fargo Securities, LLC, as the representative of the initial purchasers (the “Initial Purchasers”), with respect to a private offering (the “Notes Offering”) by the Company of $500,000,000 in aggregate principal amount of 5.875% senior notes due 2034 (t…
Other Events. On May 14, 2026, the Company issued a press release, made pursuant to Rule 135c promulgated under the Securities Act of 1933, as amended, announcing the pricing of the Notes Offering. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein. The forward-looking statements contained in this Form 8-K are qualified by the information contained under the heading “ Forward-Looking Statements ” in the press release attached as Exhibit 99.1 he…
Results of Operations and Financial Condition. On April 30, 2026, Encompass Health Corporation (“Encompass Health” or the “Company”) issued a press release reporting the financial results of the Company for the three months ended March 31, 2026. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference. The Company uses “same-store” comparisons to explain the changes in certain performance metrics within its financial statements. Same-store co…
Regulation FD Disclosure. See Item 2.02, “Results of Operations and Financial Condition,” above. In addition, a copy of the supplemental information which will be discussed during the Company’s earnings call at 10:00 a.m. Eastern Time on Friday, May 1, 2026 is attached to this report as Exhibit 99.2 and incorporated herein by reference. Note Regarding Presentation of Non-GAAP Financial Measures The financial data contained in the press release and supplemental information include non-GAAP fin…
Termination of a Material Definitive Agreement. As disclosed in
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The disclosure required by this item is included in
Entry into a Material Definitive Agreement. On March 9, 2026 (the “Closing Date”), Encompass Health Corporation (the “Company”) entered into the Credit Agreement (the “2026 Credit Agreement”), by and among the Company, certain of its subsidiaries, as guarantors, Truist Bank, as administrative agent and collateral agent, and various other lenders. In connection with the execution of the 2026 Credit Agreement, the Company paid off all outstanding amounts, and terminated the commitments, as of t…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Election of Director. This Current Report on Form 8-K amends and supplements the Current Report on Form 8-K originally filed by Encompass Health Corporation (the “Corporation”) with the Securities and Exchange Commission on February 2, 2026 related to the appointment of a new member of the Board of Directors (the “Board”) of the Corporation. On Jan…
Regulation FD Disclosure. See Item 2.02, “Results of Operations and Financial Condition,” above. In addition, a copy of the supplemental information which will be discussed during the Company’s earnings call at 10:00 a.m. Eastern Time on Friday, February 6, 2026 is attached to this report as Exhibit 99.2 and incorporated herein by reference. Note Regarding Presentation of Non-GAAP Financial Measures The financial data contained in the press release and supplemental information include non-GAA…
Results of Operations and Financial Condition. On February 5, 2026, Encompass Health Corporation (“Encompass Health” or the “Company”) issued a press release reporting the financial results of the Company for the three months and year ended December 31, 2025. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference. The Company uses “same-store” comparisons to explain the changes in certain performance metrics within its financial statements.…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Election of Director. On January 30, 2026, the Board of Directors (the “Board”) of Encompass Health Corporation (the “Company”), upon the recommendation of its Nominating/Corporate Governance Committee, elected Cain A. Hayes as director. The Board has not yet appointed Mr. Hayes to a committee. The Board has determined Mr. Hayes is independent for…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.